These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21616094)

  • 1. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
    Ölschläger S; Neyts J; Günther S
    Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
    Leyssen P; Balzarini J; De Clercq E; Neyts J
    J Virol; 2005 Feb; 79(3):1943-7. PubMed ID: 15650220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-yellow fever virus activity of ribavirin is independent of error-prone replication.
    Leyssen P; De Clercq E; Neyts J
    Mol Pharmacol; 2006 Apr; 69(4):1461-7. PubMed ID: 16421290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells.
    Khan M; Dhanwani R; Patro IK; Rao PV; Parida MM
    Antiviral Res; 2011 Jan; 89(1):1-8. PubMed ID: 21070810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5'-triphosphate, not with inhibition of IMP dehydrogenase.
    Sun Y; Chung DH; Chu YK; Jonsson CB; Parker WB
    Antimicrob Agents Chemother; 2007 Jan; 51(1):84-8. PubMed ID: 17060520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro.
    Dal Pozzo F; Galligioni V; Vaccari F; Gallina L; Battilani M; Scagliarini A
    Res Vet Sci; 2010 Apr; 88(2):339-44. PubMed ID: 19781726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro.
    Smee DF; Bray M; Huggins JW
    Antivir Chem Chemother; 2001 Nov; 12(6):327-35. PubMed ID: 12018677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.
    Borroto-Esoda K; Myrick F; Feng J; Jeffrey J; Furman P
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4387-94. PubMed ID: 15504868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes.
    Balzarini J; Lee CK; Schols D; De Clercq E
    Biochem Biophys Res Commun; 1991 Jul; 178(2):563-9. PubMed ID: 1650194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of the IMPDH enzyme as potential anti-bovine viral diarrhoea virus agents.
    Stuyver LJ; Lostia S; Patterson SE; Clark JL; Watanabe KA; Otto MJ; Pankiewicz KW
    Antivir Chem Chemother; 2002 Nov; 13(6):345-52. PubMed ID: 12718406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
    Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Winslow S; Hoopes J; Li JK; Lee J; Carson DA; Cottam HB; Sidwell RW
    Antiviral Res; 2006 Aug; 71(1):53-63. PubMed ID: 16621037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
    Sokoloski JA; Sartorelli AC
    Mol Pharmacol; 1985 Dec; 28(6):567-73. PubMed ID: 2867464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens.
    Tong X; Smith J; Bukreyeva N; Koma T; Manning JT; Kalkeri R; Kwong AD; Paessler S
    Antiviral Res; 2018 Jan; 149():34-40. PubMed ID: 29126899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism-based design of inosine 5-monophosphate dehydrogenase inhibitors: synthesis and biological activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives.
    Minakawa N; Matsuda A
    Curr Med Chem; 1999 Jul; 6(7):615-28. PubMed ID: 10390604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
    Balzarini J; Karlsson A; Wang L; Bohman C; Horská K; Votruba I; Fridland A; Van Aerschot A; Herdewijn P; De Clercq E
    J Biol Chem; 1993 Nov; 268(33):24591-8. PubMed ID: 7901217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system.
    Mori K; Ikeda M; Ariumi Y; Dansako H; Wakita T; Kato N
    Virus Res; 2011 Apr; 157(1):61-70. PubMed ID: 21320556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Junin virus RNA synthesis by an antiviral acridone derivative.
    Sepúlveda CS; García CC; Fascio ML; D'Accorso NB; Docampo Palacios ML; Pellón RF; Damonte EB
    Antiviral Res; 2012 Jan; 93(1):16-22. PubMed ID: 22027649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
    Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
    Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of EICAR on infectious pancreatic necrosis virus replication.
    Jashés M; Mlynarz G; De Clercq E; Sandino AM
    Antiviral Res; 2000 Jan; 45(1):9-17. PubMed ID: 10774586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro study of antiviral activity of mycophenolic acid on Brazilian orthobunyaviruses.
    Livonesi MC; Moro de Sousa RL; Moraes Figueiredo LT
    Intervirology; 2007; 50(3):204-8. PubMed ID: 17283446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.